Nucleic Acid Labeling Market Analysis

  • Report ID: 4299
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Nucleic Acid Labeling Market Segmentation:

Product Type Segment Analysis

The global nucleic acid labeling market is segmented and analyzed for demand and supply by product type into reagents, and kits. Among these segments, the kits segment is anticipated to capture the largest market size in the global nucleic acid labeling market. The growing application of DNA labeling and detection products for detection and purification is expected to drive segment growth during the forecast period. Moreover, the surge in cases of COVID-19 along with the development of advanced labeling kits by key manufacturers for COVID- 19 diagnostics, is further anticipated to fuel segment growth. For instance, Perkin Elmer Inc's new COVID-19 nucleic acid detection kit is an in vitro real-time RT-PCR diagnostic kit for detecting nucleic acid from SARS-CoV-2 in humans with 48 tests included in the kit. The kits help to avoid long waiting times in lines at hospitals and the risk of infections is more in health facilities. The home-tested kits also help to prevent traveling chargers. Even health professionals will save time as everything is assembled in the kit which is disposable after use.

Application Segment Analysis

The global nucleic acid labeling market is also segmented and analyzed for demand and supply by application into DNA sequencing, PCR, FISH, microarray, In situ hybridization, botting, and others. The In-situ hybridization segment is estimated to garner the largest share. The rising prevalence of genetic disorders and increasing use of In-situ hybridization in the manufacturing of cancer and genetic disorder drugs or medicines. The increasing growth of infections among people as well as research and development funds to improve the market segment growth is estimated to drive the growth of the market. It is also used to understand the disease such as the DNA or chromosomal abnormalities that cause the disorder. Rising pharmaceutical, diagnostic, and biopharmaceutical companies boost the growth of the segment. As per the estimations of the World Health Organization, about 10 in 1000 people are affected by the monogenic disease across the world.

Our in-depth analysis of the global market includes the following segments:

          By Product Type

  • Reagents
  • Kits

          By Labeling Technique

  • PCR
  • Nick Translation
  • Random Primer
  • In Vitro Transcription
  • Reverse Transcription
  • End Labeling

          By Application

  • DNA sequencing
  • PCR
  • FISH
  • Microarray
  • In Situ Hybridization
  • Blotting
  • Others

         By End User

  • Diagnostic & Research Centers
  • Hospitals

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of nucleic acid labeling is assessed at USD 2.86 Billion.

The global nucleic acid labeling market size was valued at more than USD 2.66 Billion in 2025 and is expected to register a CAGR of over 8.2%, exceeding USD 5.85 Billion revenue by 2035.

North America’s nucleic acid labeling market will secure around 40.6% share by 2035, fueled by rising genomics research and healthcare expenditure.

Key players in the market include Thermo Fisher Scientific Inc., New England Biolabs, PerkinElmer Inc., F. Hoffmann La-Roche AG, GENERAL ELECTRIC COMPANY, Merck KGaA, Enzo Biochem Inc., Promega Corporation, Vector Laboratories, Agilent Technologies, Inc., LubioScience GmbH.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos